Akkure Genomics is at the forefront of leveraging AI and genomics to revolutionise cancer trial recruitment. By analysing patients' genomic data, our AI-powered algorithms identify potential trials that may be relevant to cancer treatment, based on genetic profiles rather than traditional eligibility criteria. This precision approach increases the likelihood of success in trials and leads to more personalised and effective treatments. 

 

Akkure Genomics is dedicated to supporting cancer charities and improving patient outcomes through their Cancer Trials Finder, an AI and genomics-driven tool. In addition Akkure Genomics can use AI to work with a government’s national genomic programmes to enhance clinical trial matching, benefiting patients and pharmaceutical companies and it’s nation’s health.